BeStock  
Stocks › Biotechnology › PRAX

Praxis Precision Medicines PRAX

US equityMarket cap rank #1557Biotechnology
$300.43 −$10.47 (-3.37%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $300.43 0.00%
Open$310.07
Prev close$310.90
Day range$298.54 – $314.15
Volume806.2K
Market cap$8.40B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-25.6x
CheapRich

Near the bottom of its 5-year range · 3rd percentile, 5-year average -7.1x

Price / book7.3x
CheapRich

Near the top of its 5-year range · 83rd percentile, 5-year average 4.4x

#4747 of 5331 stocks by PB (1 = cheapest)

Price / sales1,229.0x
CheapRich

Near the top of its 5-year range · 94th percentile, 5-year average 385.8x

#5096 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-31x-19x-8x4xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$325.07
Price vs. fair value-7.6%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 7.28 – 4.44 83% (pricier than usual) #4747 of 5331 (1 = cheapest)
PE -25.60 -20.35 -7.12 3% (cheaper than usual) –
PS 1,228.96 55.61 385.80 94% (pricier than usual) #5096 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on PRAX.

Sign in to join the discussion.

Scroll to Top